Keyword: Horizon Therapeutics
News
14.10.2023
-
Amgen has completed its acquisition of Horizon Therapeutics for approximately $27.8 billion. The acquisition was approved by the US Federal Trade Commission (FTC) in...
News
05.09.2023
-
The US Federal Trade Commission (FTC) wants to clear the takeover of Irish biotech company Horizon Therapeutics by pharmaceutical group Amgen. Following concessions by...
News
27.06.2023
-
Six US states – New York, California, Illinois, Wisconsin, Minnesota and Washington – have joined the Federal Trade Commission's lawsuit to block Amgen's proposed nearly...
News
20.06.2023
-
The US Federal Trade Commission’s lawsuit to potentially block the $27.8 merger of Amgen and Horizon Therapeutics is creating heightened concern in the international...
News
23.05.2023
-
Reacting to a US Federal Trade Commission (FTC) restraining order, Amgen said it won’t close its $28 billion deal for Horizon until the courts have ruled. The FTC says...
News
17.05.2023
-
Calling the deal announced late last year an alarming sign for biopharma, the US Federal Trade Commission (FTC) is seeking to block the closing of Amgen’s proposed $28...
News
08.02.2023
-
Amgen’s proposed acquisition of Horizon Therapeutics for $28.7 billion, including debt, would be the largest healthcare deal since AstraZeneca’s $39 billion purchase of...
News
15.12.2022
-
Amgen has agreed to buy Horizon Therapeutics for $28.3 billion including debt, boosting its portfolio of drugs for rare autoimmune and inflammatory diseases and beating...